SANGAMO THERAPEUTICS, INC. Increase (Decrease) in Income Taxes Receivable
SANGAMO THERAPEUTICS, INC. (SGMOQ) reported Increase (Decrease) in Income Taxes Receivable of -$4.53 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInIncomeTaxesReceivable · last filed 2026-05-14
- SANGAMO THERAPEUTICS, INC. increase (decrease) in income taxes receivable for the quarter ending 2026-03-31 was -$4.53M.
- SANGAMO THERAPEUTICS, INC. increase (decrease) in income taxes receivable for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- SANGAMO THERAPEUTICS, INC. increase (decrease) in income taxes receivable for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- SANGAMO THERAPEUTICS, INC. increase (decrease) in income taxes receivable for the quarter ending 2025-06-30 was $0.00.
- SANGAMO THERAPEUTICS, INC. increase (decrease) in income taxes receivable for fiscal 2025 was $0.00.
- SANGAMO THERAPEUTICS, INC. increase (decrease) in income taxes receivable for fiscal 2024 was -$556.00K, a 114.90% decline from fiscal 2023.
- SANGAMO THERAPEUTICS, INC. increase (decrease) in income taxes receivable for fiscal 2023 was $3.73M.
| Period end | Increase (Decrease) in Income Taxes Receivable 3 month | Increase (Decrease) in Income Taxes Receivable 6 month | Increase (Decrease) in Income Taxes Receivable 9 month | Increase (Decrease) in Income Taxes Receivable 12 month |
|---|---|---|---|---|
| 2026-03-31 | -$4.53M 10-Q · filed 2026-05-14 | -$4.53M derived: sum of 2 quarters · filed 2026-05-14 | -$4.53M derived: sum of 3 quarters · filed 2026-05-14 | -$4.53M derived: sum of 4 quarters · filed 2026-05-14 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $0.00 derived: sum of 2 quarters · filed 2026-03-30 | $0.00 derived: sum of 3 quarters · filed 2026-03-30 | $0.00 10-K · filed 2026-03-30 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $0.00 derived: sum of 2 quarters · filed 2025-11-06 | $0.00 10-Q · filed 2025-11-06 | $39.00K derived: sum of 4 quarters · filed 2026-05-14 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $0.00 10-Q · filed 2025-08-07 | $39.00K derived: sum of 3 quarters · filed 2026-05-14 | $576.00K derived: sum of 4 quarters · filed 2026-05-14 |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-14 | $39.00K derived: sum of 2 quarters · filed 2026-05-14 | $576.00K derived: sum of 3 quarters · filed 2026-05-14 | -$1.95M derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $39.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $576.00K derived: sum of 2 quarters · filed 2026-03-30 | -$1.95M derived: sum of 3 quarters · filed 2026-03-30 | -$556.00K 10-K · filed 2026-03-30 |
| 2024-09-30 | $537.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$1.99M derived: sum of 2 quarters · filed 2025-11-06 | -$595.00K 10-Q · filed 2025-11-06 | |
| 2024-06-30 | -$2.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$1.13M 10-Q · filed 2025-08-07 | ||
| 2024-03-31 | $1.39M 10-Q · filed 2025-05-12 | |||
| 2023-12-31 | $3.73M 10-K · filed 2025-03-17 |